Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 222

The DOI matches its Crossref record.

Ineffectiveness of Neurokinin-1 Antagonist in Acute Migraine: A Crossover Study

Goldstein, DJ, Wang, O, Saper, JR, Stoltz, R, Silberstein, SD, Mathew, NT · 1997 · Cephalalgia

Abstract

Lanepitant is a high-affinity selective neurokinin-1 receptor (NK-1) and is effective in the dural inflammation model of acute migraine. Lanepitant 30, 80, and 240 mg given orally was evaluated in a double-blind, placebo-controlled crossover study to determine its effect in reducing migraine pain and severity of associated symptoms. Outpatients treated four migraine headaches of moderate or severe pain intensity with study drug according to a randomization schedule. They recorded their pain intensity and severity of migraine-associated symptoms at 30, 60, 90, and 120 min. Although 53 patients were randomly allocated to a treatment sequence, only 40 patients, completed all treatments. There was no statistically significant difference in improvement in migraine pain at any time for any of the treatments. Additionally, there was no change in severity of migraine associated symptoms associated with lanepitant therapy. No adverse events could be attributed to lanepitant Lanepitant was ineffective orally in treating acute migraine in this trial. This may be due to poor bioavailability during a migraine attack. Alternatively, the neurogenic inflammation hypothesis may not apply to migraine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1468-2982.1997.1707785.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 222

Metadata

Authors
Goldstein, D., Wang, O., Saper, Jr., Stoltz, R., Silberstein, S., & Mathew, N.
Venue
Cephalalgia
Published
1997-11
Volume
17
Issue
7
Pages
785-790
ISSN
  • 0333-1024 (ISSN-L)
  • 1468-2982
OpenAlex
W2038649996
Cited by
222
References
0
FWCI
9.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ineffectiveness of Neurokinin-1 Antagonist in Acute Migraine: A Crossover Study. https://app.cochat.ai/papers/10.1046/j.1468-2982.1997.1707785.x
The paper
Goldstein, D., Wang, O., Saper, Jr., Stoltz, R., Silberstein, S., & Mathew, N. (1997). Ineffectiveness of Neurokinin-1 Antagonist in Acute Migraine: A Crossover Study. Cephalalgia. https://doi.org/10.1046/j.1468-2982.1997.1707785.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.